Product Code: RP-ID-10008252 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10008252
Market Overview:
Global Urinary Catheters Market Size, Growth, Opportunity and Forecast
"The global urinary catheter market is anticipated to be worth USD ~3 billion by the end of 2021 and is expected to grow at a compound annual growth rate (CAGR) of ~6% from 2022 to 2030. The increase in the number of patients suffering from urinary tract infections (UTI) and urethral obstruction, the increase in cases of urinary tract or reproductive organ tumors, and the rapid growth of the elderly population are some of the key factors driving market growth. A urinary catheter is a partially flexible tube used to drain urine from the bladder. The materials used to make these catheters include plastic, rubber, and silicone. Doctors recommend the use of a urinary catheter to treat urinary incontinence (UI), urinary retention, prostate surgery, or other medical conditions such as spinal cord injury, multiple sclerosis, or dementia. Urinary incontinence (UI) is one of the steadily increasing urinary system diseases in the United States, driving the development of the entire market. According to the National Center for Biotechnology Information (NCBI), women are more susceptible to the risk of UI.
The growing elderly population is another key factor in the increase in the need for catheters. As we age, the urinary system will be affected, such as changes in the bladder wall, weakened bladder muscles, or bladder obstruction. Muscles become weak. Or enlarged prostate (in the case of men). Older people face bladder control problems, such as leaking urine or UI or urinary retention and chronic kidney disease (CKD). Urinary retention due to bladder neck obstruction, neurological abnormalities, and posterior urethral stricture is more common.
More and more patients suffering from this urinary dysfunction require urinary catheterization to process and drain urine, so the market demand for these products is expected to increase. When the basic criteria for reimbursement are met, intermittent catheterization is covered by Medicare and Medicaid. The Medicaid program reimburses patients for 120 intermittent catheters each month. Reimbursement includes straight catheter kits, coude and various brands of catheters with hydrophilic and antibacterial coatings, while the Medicare plan allows reimbursement for up to 200 sterile, single-use intermittent catheters per month.
For the reimbursement of these intermittent catheters, patients need a prescription to verify whether they have urinary retention or urinary incontinence. Medicare coverage also includes coude tip catheters, depending on the users preferences and needs. Therefore, the country's favorable repayment situation also supports market growth. According to the National Abstinence Association, people aged 40 and over are mainly affected by overactive bladder and the urge to urinate. Urinary incontinence is more prominent in the elderly, leading to low quality of life and low morbidity.
PRODUCT INFORMATION:
The intermittent catheter segment will lead the market in 2020, accounting for the largest revenue share of more than 50%. Intermittent urinary catheter is a medical device used to empty the bladder. Provide an effective solution for continuous drainage catheters. Intermittent catheterization is considered the gold standard for emptying the bladder in patients with spinal cord injury and neurogenic bladder problems. These products are superior to indwelling catheters, because indwelling catheters usually cause urinary tract infection (UTI).
In addition, the availability of reimbursement for these catheters under Medicaid and Medicare plans contributes to the growth of this market segment. During the forecast period, external catheters are expected to be the fastest-growing product segment.
These catheters are used for male patients and are an excellent choice over other catheters, such as conventional catheters that need to be inserted through the urethra. Major companies provide advanced external catheter products. For example, BD (C.R. Bard) offers a series of unique male catheters, such as ULTRAFLEX male external catheters, which can provide safer placement compared to non-silicone sheaths.
APPLICATION INSIGHT:
The urinary incontinence (UI) segment will lead the market in 2020, accounting for the major revenue share, exceeding 35%. According to the American Urological Association, one-third of the population suffers from UI, and women are more common than men.
It has a significant impact on long-term care facilities and is one of the main reasons for the elderly to enter institutional care. Bladder incontinence is caused by many factors, such as age-induced urinary tract changes, urinary tract infections, and other indirect diseases such as diabetes, stroke, cancer, and mobility problems. The most common types of UI found in women include stress incontinence and urge incontinence.
REGIONAL INFORMATION:
North America will dominate the market in 2020, accounting for more than 32% of revenue, and it is expected to see substantial growth in the future. This increase can be attributed to increasing awareness of urinary system infections, the existence of well-established health centers, and the availability of well-trained doctors in the area.
The regional market is also driven by an increasing number of specific diseases, such as urinary retention, bladder obstruction, UI, BPH and bladder cancer. UI is a very common disease and is most publicly discussed in regional media, newspapers, and TV advertisements. From 2022 to 2030, the Asia-Pacific region is expected to record the fastest compound annual growth rate. The increasing prevalence of BPH, spinal cord injury and urinary tract infection (UTI) is driving demand for products in the region. UTI is one of the most prevalent infectious diseases in the region. It is associated with significant morbidity and mortality, especially in hospitals, and brings a heavy economic burden to the community.
Key companies and market share prospects:
Top companies focus on new product launches, technological advancements, and growth strategies, such as mergers and acquisitions, to maintain their market position. For example, in 2019 Hollister launched the Infyna Chic intermittent urinary catheter in the female hydrophilic catheter product. Some of the major companies operating in the global urinary catheter market include: Hollister, Inc. Medtronic PLC Boston Scientific Corp Becton Dickinson And Company (CR Bard, Inc.) Cook Medical Teleflex, Inc. Medline Industries, Inc. J and M Urinary Catheters Limited Responsible company .
MARKET SEGMENTS COVERED BY THE REPORT:
The report forecasts global, regional and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research reports on the global urinary catheter market based on products, applications and regions: product outlook (revenue, million dollars, 2022-2030
IntermittentFoley / ResidenceExternalApplication outlook (revenue, million dollars, 2022-2030 Benign Prostatic Hyperplasia (BPH) and Prostate Surgery Urinary Incontinence Spinal Cord Injury Others.
MARKET SEGMENTS COVERED BY THE REPORT :
The report forecasts global, regional and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research reports on the global urinary catheter market based on products, applications and regions: product outlook (revenue, million dollars, 2022-2030) IntermittentFoley / ResidenceExternalApplication outlook (revenue, million dollars, 2022-2030) Benign Prostatic Hyperplasia (BPH) and Prostate Surgery Urinary Incontinence Spinal Cord Injury Others. "
1. B. Braun Melsungen AG
2. Boston Scientific Corporation
3. Coloplast A/S
4. Convatec Group PLC
5. C.R. Bard, Inc.
6. Medtronic PLC
7. Teleflex Incorporated
8. Wellspect Healthcare (A Subsidiary of Dentsply IH Ltd.)
9. Bactiguard
10. Cook Medical
11. Hollister Incorporated
12. Pacific Hospital Supply Co. Ltd
13. Rochester Medical Corporation
Related Reports
Proof of Quality & Reliability
